Abstracts

GREATER BURDEN OF INTRACRANIAL ARTERIAL-WALL ENHANCEMENT IN PERSONS LIVING WITH HIV

Persons living with HIV (PWH) are at higher risk of stroke compared with age-matched persons without HIV. However, the mechanisms underlying increased cerebrovascular risk in PWH are unclear. In particular, the contribution of intracranial arterial disease to HIV-associated stroke remains poorly defined. We compared intracranial vessel wall magnetic resonance imaging (VW-MRI), which can demonstrate atherosclerotic disease even…

NUCLEAR UNCOATING OF HIV-1 OCCURS NEAR SITES OF INTEGRATION

A critical step in HIV-1 replication is the disassembly (uncoating) of the viral core.  Remarkably, the timing and intracellular location of HIV-1 uncoating remain unknown.  Studies of HIV-1 uncoating have been hampered by an inability to accurately quantify capsid protein (CA) loss from the viral complexes and by an inability to identify rare infectious viral…

RECONSTITUTION OF HIV-1 CAPSID-DEPENDENT REPLICATION AND INTEGRATION IN VITRO

To initiate an infection, the HIV-1 genome must be reverse transcribed and integrated into the DNA of the host cell.  Despite progress in characterizing and inhibiting these viral processes, detailed mechanistic and structural studies remain challenging because they are executed by individual preintegration complexes deep within cells. To address these limitations, we have reconstituted the…

STRUCTURAL ANALYSES OF A BOUND ANTI-CD4 ADNECTIN INHIBITOR OF HIV-1

GSK3732394 is a multi-specific biologic inhibitor of HIV entry currently under clinical evaluation. A key component of this molecule is an Adnectin that binds to CD4 and inhibits downstream actions of gp160. Studies were performed to help elucidate the binding site of the Adnectin on CD4 and understand the mechanism of inhibition. Hydrogen-deuterium exchange mass…